Second Quarter Earnings July 29, 2025 1 Management Presenters Forward-Looking Statements This presentation contains forward-looking statements. The Company desires to take advantage of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995 and is including this statement for the express purpose of availing itself of the protections of the safe harbor with respect to all forward-looking statements. Therefore, the Company wishes to caution each participant to consider carefully the ...

America's First Transcontinental Railroad Union Pacific and Norfolk Southern to Combine 1 AMERICA'S FIRST TRANSCONTINENTAL RAILROAD 7/29/2025 Cautionary Information This presentation and related materials contain statements that are forward looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times that, or by which, such performance or results will be achieved. Forward-looking information, ...

Financial Performance (First Six Months 2025) - Sales increased by 18% at CER (Constant Exchange Rates)[17] - Operating profit increased by 29% at CER[17] - Sales were positively impacted by gross-to-net sales adjustments of approximately DKK 3 billion in Q2 related to 340b[18] - Operating profit was positively impacted by ocedurenone impairment of DKK 5.7 billion in Q2 2024[19] - Operating profit was partially countered by the acquisition of the three former Catalent manufacturing sites of approximately DKK 2.6 billion[19] Revised Financial Outlook for 2025 - Sales growth outlook revised to 8% to 14% at CER, lowered from the previous guidance of 13% to 21%[20] - Reported sales growth is expected to be around 4 percentage points lower[20] - Operating profit growth outlook revised to 10% to 16% at CER, lowered from the previous guidance of 16% to 24%[20] - Reported operating profit growth is expected to be around 7 percentage points lower[20] - Financial items (net) are now expected to be a gain of around DKK 3 billion, compared to the previous expectation of around DKK 0.9 billion[20] - Free cash flow is now projected to be DKK 35 to 45 billion, down from the previous forecast of DKK 56 to 66 billion[20] Factors Impacting Outlook - Lower US Wegovy outlook due to compounding, slower market expansion, and competition[24] - Lower US Ozempic outlook due to competition[24] - Lower International Operations (IO) Wegovy outlook due to slower market expansion and competition in select markets[24] - Lower volume growth of GLP-1 treatments in the US, amplified by related cash flow implications from the US gross-to-net system[23] Executive Leadership Changes - Maziar Mike Doustdar will become President and CEO as of August 7, 2025[14]

Commvault Fiscal Q1'26 Earnings Presentation JULY 2025 © Commvault 2025 Forward-Looking Statements This presentation contains forward-looking statements regarding future events or the expected financial performance of our company, including statements about our outlook for future periods and related guidance. Commvault does not provide forward-looking guidance on a GAAP basis as certain financial information, the probable significance of which cannot be determined, is not available and cannot be reasonably ...

GeneDx (Nasdaq: WGS) 2Q 2025 Earnings Presentation July 29, 2025 On average: 16 tests and 5 years before an accurate diagnosis Forward Looking Statements This presentation contains certain forward-looking statements within the meaning of the federal securities laws, including statements regarding our future performance, future operations, plans, objectives of management, and our market opportunity, including our expected full year 2025 reported revenue, volume, adjusted gross margin and adjusted net income. ...

Financial Performance - FY2025 - Organic sales grew by 2% driven by volume and pricing[7] - Core earnings per share (EPS) increased by 4% to $6.83 compared to the prior year[8] - Currency neutral core EPS also increased by 4%[8] - Adjusted free cash flow productivity was 87%[9] Financial Performance - Q4 FY2025 - Organic sales grew by 2%[26] - Core EPS grew by 6%[26] - Currency neutral core EPS grew by 5%[26] - Adjusted free cash flow productivity was 110%[26] Shareholder Returns - The company returned $9.9 billion to shareholders via dividends and share repurchases in FY2025[23] - Total cash returned to owners over the past 10 years amounts to $151 billion[23] - Share repurchase amounted to $6.5 billion in FY2025[23] FY2026 Guidance - The company projects organic sales growth of +0% to +4%[55] - Net sales growth is projected to be +1% to +5%, including a 1% positive impact from foreign exchange and acquisitions/divestitures[55] - Core EPS growth is guided at +0% to +4%[57] - The company anticipates paying approximately $10 billion in dividends and repurchasing approximately $5 billion in shares[60]

Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings. These forward-looking statements speak only as of the date of this presentation and except to the extent required by applicable law, the Company does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise. Q 2 2 0 2 5 R E S U L T S | 2 Sec ...

Transaction Overview - Baker Hughes will acquire Chart Industries for $210 per share in cash, implying a $13.6 billion enterprise value[23, 60] - The transaction is valued at approximately 9x Chart's 2025E Consensus EBITDA, including run-rate cost synergies[23, 60] - Baker Hughes expects to realize $325 million in annualized cost synergies from the acquisition[23, 60, 63] - Baker Hughes anticipates double-digit adjusted EPS accretion in the first full calendar year after the deal closes[24, 60] - The company is committed to maintaining an A credit rating[24, 64] Strategic Rationale - The acquisition transforms Baker Hughes' Industrial & Energy Technology (IET) segment and increases focus on attractive energy and industrial end markets[21, 76] - The combined company is positioned for success with 55% of revenue from IET and 45% from OFSE (Oilfield Services and Equipment) in 2025E[33, 75] - The acquisition expands IET's exposure to non-O&G markets, increasing from ~15% to ~70%[39] - Chart Industries' 2024 revenue was $4.2 billion with a 24% adjusted EBITDA margin[27, 28] Synergies and Financial Impact - $325 million in cost synergies are expected, with $230 million from supply chain efficiencies and $95 million from commercial opportunities[23, 63] - The company is targeting a net debt to LTM EBITDA ratio of 10x – 15x within 24 months post-close[60, 65] - Baker Hughes expects double-digit ROIC by year 5 post-close[60]

Q2 2025 Performance Highlights - Backlog reached a record high of $688 million, a 76% increase year-over-year[6] - Orders hit a record of $274 million, resulting in a book-to-bill ratio of approximately 1.5x[6] - Revenue increased by 35% year-over-year to $185 million, exceeding consensus estimates[6] - Adjusted EBITDA was $23.3 million, also above consensus estimates[6] - Adjusted EPS was $0.24, in line with consensus estimates[6] H1 2025 Results and Outlook - H1 Bookings were approximately $502 million, up 76% year-over-year, with a book-to-bill ratio of approximately 1.4x[10] - H1 Revenue was approximately $362 million, a 37% increase year-over-year[10] - The company is updating its FY2025 revenue outlook to $725 million - $775 million, reflecting an approximate $25 million increase[11] - The company maintains its Adjusted EBITDA outlook at $90 million - $100 million, expecting an approximate 50% year-over-year increase[11] Financial Metrics - Q2 2025 Orders increased by 95% year-over-year to $274 million[16] - Trailing Twelve Months (TTM) Orders increased by 58% to $883 million[16] - Q2 2025 Adjusted EBITDA increased by 45% year-over-year to $23.3 million[16] - Q2 2025 Revenue increased by 35% year-over-year to $185 million[16]

Financial Performance - Revenue increased by 4% to a record $635 million in Fiscal Quarter 1 2026[6], compared to $609 million in the same period of the previous year[9] - Gross profit margin was 29.2%[6] - Earnings per share (EPS) decreased by 5% to $3.76[6], compared to $3.94 in the same period of the previous year[13] - Operating cash flow generated was $137 million[6], a 3% increase compared to $133 million in the same quarter of the previous year[21] Segment Results - Heavy Materials (including Cement, Concrete, and Aggregates) revenue increased to $421 million[17] from $400 million[17], with cement sales volume up by 2%[17] and aggregates sales volume up by 117%[17] - Light Materials (Wallboard) revenue increased to $251 million[20] from $248 million[20], with wallboard sales volume up by 4%[20], but wallboard net sales prices decreased by 3%[20] Capital Allocation - $87 million was returned to shareholders[6] - 358,000 shares were repurchased for $79 million[6] - Quarterly dividend was paid[6] Financial Position - Net Debt to Adjusted EBITDA ratio was 1.6x as of June 30, 2025[24], compared to 1.5x as of March 31, 2025[24] - Net Debt was $1,258 million as of June 30, 2025[35], compared to $1,226 million as of March 31, 2025[35]